Wealthcare Advisory Partners LLC Halozyme Therapeutics, Inc. Transaction History
Wealthcare Advisory Partners LLC
- $3.43 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
519Shares Held
124MCall Options Held
208KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$1.07 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$781 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$353 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$245 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$225 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.45B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...